HPV-specific oligonucleotides

HPV-specific oligonucleotides

This invention relates to the human papillomavirus. More specifically, this invention relates to the inhibition, treatment, and diagnosis of human papillomavirus-associated lesions using synthetic oligonucleotides complementary to human papillomavirus nucleic acid. The present invention discloses sy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Roberts, Peter C, Frank, Bruce L, Szymkowski, David E, Mills, John S, Goodchild, John, Wolfe, Jia L, Kilkuskie, Robert E, Greenfield, Isobel M, Sullivan, Veronica
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Roberts, Peter C
Frank, Bruce L
Szymkowski, David E
Mills, John S
Goodchild, John
Wolfe, Jia L
Kilkuskie, Robert E
Greenfield, Isobel M
Sullivan, Veronica
description This invention relates to the human papillomavirus. More specifically, this invention relates to the inhibition, treatment, and diagnosis of human papillomavirus-associated lesions using synthetic oligonucleotides complementary to human papillomavirus nucleic acid. The present invention discloses synthetic oligonucleotides complementary to a nucleic acid spanning the translational start site of human papillomavirus gene E1, and including at least 15 nucleotides. Also disclosed are methods and kits for inhibiting the replication of HPV, for inhibiting the expression of HPV nucleic acid and protein, for detection of HPV, and for treating HPV infections.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_06509149</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>06509149</sourcerecordid><originalsourceid>FETCH-uspatents_grants_065091493</originalsourceid><addsrcrecordid>eNrjZJD1CAjTLS5ITc5My0xWyM_JTM_PK03OSc0vyUxJLeZhYE1LzClO5YXS3AwKbq4hzh66pcUFiSWpeSXF8elFiSDKwMzUwNLQxNKYCCUAt_UlMA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HPV-specific oligonucleotides</title><source>USPTO Issued Patents</source><creator>Roberts, Peter C ; Frank, Bruce L ; Szymkowski, David E ; Mills, John S ; Goodchild, John ; Wolfe, Jia L ; Kilkuskie, Robert E ; Greenfield, Isobel M ; Sullivan, Veronica</creator><creatorcontrib>Roberts, Peter C ; Frank, Bruce L ; Szymkowski, David E ; Mills, John S ; Goodchild, John ; Wolfe, Jia L ; Kilkuskie, Robert E ; Greenfield, Isobel M ; Sullivan, Veronica ; Hybridon, Inc</creatorcontrib><description>This invention relates to the human papillomavirus. More specifically, this invention relates to the inhibition, treatment, and diagnosis of human papillomavirus-associated lesions using synthetic oligonucleotides complementary to human papillomavirus nucleic acid. The present invention discloses synthetic oligonucleotides complementary to a nucleic acid spanning the translational start site of human papillomavirus gene E1, and including at least 15 nucleotides. Also disclosed are methods and kits for inhibiting the replication of HPV, for inhibiting the expression of HPV nucleic acid and protein, for detection of HPV, and for treating HPV infections.</description><language>eng</language><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6509149$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,777,799,882,64018</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6509149$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Roberts, Peter C</creatorcontrib><creatorcontrib>Frank, Bruce L</creatorcontrib><creatorcontrib>Szymkowski, David E</creatorcontrib><creatorcontrib>Mills, John S</creatorcontrib><creatorcontrib>Goodchild, John</creatorcontrib><creatorcontrib>Wolfe, Jia L</creatorcontrib><creatorcontrib>Kilkuskie, Robert E</creatorcontrib><creatorcontrib>Greenfield, Isobel M</creatorcontrib><creatorcontrib>Sullivan, Veronica</creatorcontrib><creatorcontrib>Hybridon, Inc</creatorcontrib><title>HPV-specific oligonucleotides</title><description>This invention relates to the human papillomavirus. More specifically, this invention relates to the inhibition, treatment, and diagnosis of human papillomavirus-associated lesions using synthetic oligonucleotides complementary to human papillomavirus nucleic acid. The present invention discloses synthetic oligonucleotides complementary to a nucleic acid spanning the translational start site of human papillomavirus gene E1, and including at least 15 nucleotides. Also disclosed are methods and kits for inhibiting the replication of HPV, for inhibiting the expression of HPV nucleic acid and protein, for detection of HPV, and for treating HPV infections.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZJD1CAjTLS5ITc5My0xWyM_JTM_PK03OSc0vyUxJLeZhYE1LzClO5YXS3AwKbq4hzh66pcUFiSWpeSXF8elFiSDKwMzUwNLQxNKYCCUAt_UlMA</recordid><startdate>20030121</startdate><enddate>20030121</enddate><creator>Roberts, Peter C</creator><creator>Frank, Bruce L</creator><creator>Szymkowski, David E</creator><creator>Mills, John S</creator><creator>Goodchild, John</creator><creator>Wolfe, Jia L</creator><creator>Kilkuskie, Robert E</creator><creator>Greenfield, Isobel M</creator><creator>Sullivan, Veronica</creator><scope>EFH</scope></search><sort><creationdate>20030121</creationdate><title>HPV-specific oligonucleotides</title><author>Roberts, Peter C ; Frank, Bruce L ; Szymkowski, David E ; Mills, John S ; Goodchild, John ; Wolfe, Jia L ; Kilkuskie, Robert E ; Greenfield, Isobel M ; Sullivan, Veronica</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_065091493</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2003</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Roberts, Peter C</creatorcontrib><creatorcontrib>Frank, Bruce L</creatorcontrib><creatorcontrib>Szymkowski, David E</creatorcontrib><creatorcontrib>Mills, John S</creatorcontrib><creatorcontrib>Goodchild, John</creatorcontrib><creatorcontrib>Wolfe, Jia L</creatorcontrib><creatorcontrib>Kilkuskie, Robert E</creatorcontrib><creatorcontrib>Greenfield, Isobel M</creatorcontrib><creatorcontrib>Sullivan, Veronica</creatorcontrib><creatorcontrib>Hybridon, Inc</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Roberts, Peter C</au><au>Frank, Bruce L</au><au>Szymkowski, David E</au><au>Mills, John S</au><au>Goodchild, John</au><au>Wolfe, Jia L</au><au>Kilkuskie, Robert E</au><au>Greenfield, Isobel M</au><au>Sullivan, Veronica</au><aucorp>Hybridon, Inc</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HPV-specific oligonucleotides</title><date>2003-01-21</date><risdate>2003</risdate><abstract>This invention relates to the human papillomavirus. More specifically, this invention relates to the inhibition, treatment, and diagnosis of human papillomavirus-associated lesions using synthetic oligonucleotides complementary to human papillomavirus nucleic acid. The present invention discloses synthetic oligonucleotides complementary to a nucleic acid spanning the translational start site of human papillomavirus gene E1, and including at least 15 nucleotides. Also disclosed are methods and kits for inhibiting the replication of HPV, for inhibiting the expression of HPV nucleic acid and protein, for detection of HPV, and for treating HPV infections.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_06509149
source USPTO Issued Patents
title HPV-specific oligonucleotides
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T12%3A47%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Roberts,%20Peter%20C&rft.aucorp=Hybridon,%20Inc&rft.date=2003-01-21&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E06509149%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true